AI in Telehealth & Telemedicine Market by Component (Software, Service), Function (Virtual Care, Chatbot, RPM, Admin, Patient Engagement), Application (Teleneurology, TeleICU, Teleradiology), End User (Provider, Payer, Patient) - Global Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 TELEHEALTH
  • 1.2.2 TELEMEDICINE
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources for secondary data
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key sources for primary data
    • 2.1.2.2 Key objectives of primary research
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Insights from primary experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 AI IN TELEHEALTH & TELEMEDICINE MARKET OVERVIEW
• 4.2 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT AND COUNTRY
• 4.3 AI IN TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT
• 4.4 AI IN TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing adoption of virtual assistant chatbots
    • 5.2.1.2 Rising popularity of e-prescriptions
    • 5.2.1.3 Growing adoption of EHRs in healthcare settings
    • 5.2.1.4 Advancements in digital health technologies
    • 5.2.1.5 Shortage of skilled healthcare professionals
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Regulatory variations across regions
    • 5.2.2.2 Lack of advanced telemedicine infrastructure in emerging economies
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing popularity of virtual healthcare solutions
    • 5.2.3.2 Emergence of AI and ML
    • 5.2.3.3 Favorable government initiatives and reimbursement policies
    • 5.2.3.4 Rising focus on home healthcare
    • 5.2.3.5 Expansion of remote patient monitoring markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Increasing data breaches and medical identity theft cases
    • 5.2.4.2 Complexities of big data in healthcare
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.4 INDUSTRY TRENDS
  • 5.4.1 GEN AI FOR MEDICAL DOCUMENTATION
  • 5.4.2 INNOVATIONS IN REMOTE PATIENT MONITORING DEVICES
• 5.5 ECOSYSTEM ANALYSIS
  • 5.5.1 ROLE IN ECOSYSTEM
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Video conferencing and real-time communication platforms
    • 5.7.1.2 Virtual assistants and chatbots
    • 5.7.1.3 Voice recognition and natural language processing
    • 5.7.1.4 EHR integration
    • 5.7.1.5 Remote patient monitoring systems
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 Cloud computing
    • 5.7.2.2 mHealth applications
    • 5.7.2.3 Wearable devices, sensors, and IoT
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Digital therapeutics
    • 5.7.3.2 Blockchain technologies
    • 5.7.3.3 Augmented reality and virtual reality
• 5.8 TARIFF & REGULATORY ANALYSIS
  • 5.8.1 TARIFF DATA ANALYSIS
    • 5.8.1.1 Average tariff for HS code 9018
    • 5.8.1.2 Average tariff for HS code 9021
    • 5.8.1.3 Average tariff for HS code 9022
  • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8.3 REGULATORY STANDARDS
  • 5.8.4 REGULATORY REQUIREMENTS
• 5.9 TRADE ANALYSIS
  • 5.9.1 TRADE ANALYSIS FOR HSN CODE 90189099, 2019-2023
    • 5.9.1.1 Top 10 importers for HSN code 90189099
    • 5.9.1.2 Top 10 exporters for HSN code 90189099
  • 5.9.2 TRADE ANALYSIS FOR HSN CODE 9021, 2019-2023
    • 5.9.2.1 Top 10 importers for HSN code 9021
    • 5.9.2.2 Top 10 exporters for HSN code 9021
  • 5.9.3 TRADE ANALYSIS FOR HSN CODE 9022, 2019-2023
    • 5.9.3.1 Top 10 importers for HSN code 9022
    • 5.9.3.2 Top 10 exporters for HSN code 9022
• 5.10 PRICING ANALYSIS
  • 5.10.1 INDICATIVE PRICE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY COMPONENT, 2023
  • 5.10.2 AVERAGE PRICING TREND OF AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2022-2024
  • 5.10.3 PRICING MODELS
• 5.11 PORTER'S FIVE FORCES ANALYSIS
  • 5.11.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.11.2 THREAT OF NEW ENTRANTS
  • 5.11.3 THREAT OF SUBSTITUTES
  • 5.11.4 BARGAINING POWER OF BUYERS
  • 5.11.5 BARGAINING POWER OF SUPPLIERS
• 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 KEY BUYING CRITERIA
• 5.13 PATENT ANALYSIS
  • 5.13.1 PATENT PUBLICATION TRENDS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
  • 5.13.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS
• 5.14 UNMET NEEDS & END-USER EXPECTATIONS
  • 5.14.1 UNMET NEEDS
  • 5.14.2 END-USER EXPECTATIONS
• 5.15 KEY CONFERENCES & EVENTS, 2025-2026
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH CAREGILITY VIRTUAL NURSING SOLUTION
  • 5.16.2 TELADOC HEALTH TO PROVIDE MEDICARE ADVANTAGE PLAN FOR CLOSING GAPS AND BOOSTING QUALITY RATINGS
  • 5.16.3 LMH HEALTH TO REDUCE NURSE WORKLOAD WITH VIRTUAL NURSING
• 5.17 INVESTMENT & FUNDING SCENARIO
• 5.18 BUSINESS MODEL ANALYSIS
  • 5.18.1 DIRECT-TO-PATIENT (D2P) MODELS
  • 5.18.2 BUSINESS-TO-BUSINESS (B2B) MODELS
  • 5.18.3 EMPLOYER-SPONSORED MODELS
  • 5.18.4 SUBSCRIPTION-BASED MODELS
  • 5.18.5 HYBRID TELEMEDICINE MODELS
  • 5.18.6 PLATFORM-AS-A-SERVICE (PAAS) MODELS
  • 5.18.7 VALUE-BASED CARE MODELS
• 5.19 REIMBURSEMENT SCENARIO ANALYSIS

6 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT

• 6.1 INTRODUCTION
• 6.2 HARDWARE
  • 6.2.1 HIGH DEMAND FOR REMOTE PATIENT MONITORING DEVICES TO SPUR MARKET GROWTH
• 6.3 SOFTWARE
  • 6.3.1 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY
    • 6.3.1.1 EHR-centric software
      • 6.3.1.1.1 EHR-centric software to facilitate better care coordination and streamline administrative tasks
    • 6.3.1.2 Non-EHR-centric software
      • 6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate remote telehealth services
  • 6.3.2 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE
    • 6.3.2.1 Integrated software
      • 6.3.2.1.1 Better accessibility and efficiency in integrated software to revolutionize patient care
    • 6.3.2.2 Standalone software
      • 6.3.2.2.1 Flexibility and ease of usage to fuel uptake for high-quality remote patient care
  • 6.3.3 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT
    • 6.3.3.1 On-premises deployment
      • 6.3.3.1.1 On-premises deployment to enhance safety and control of inventory data
    • 6.3.3.2 Cloud-based deployment
      • 6.3.3.2.1 Cost-effectiveness and easy optimization of complex IT systems to boost market growth
• 6.4 SERVICES
  • 6.4.1 TELEHEALTH SERVICES TO REDUCE IN-PERSON CLINIC VISITS AND ENSURE BETTER TREATMENT ACCESSIBILITY FOR REMOTE AREAS

7 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION

• 7.1 INTRODUCTION
• 7.2 VIRTUAL CARE CONSULTATION
  • 7.2.1 AI-BASED VIRTUAL CARE PLANS TO AUTOMATE DOCUMENTATION AND OFFER BETTER CLINICAL DECISION SUPPORT
• 7.3 CHATBOTS & VIRTUAL ASSISTANTS
  • 7.3.1 CHATBOTS & VIRTUAL ASSISTANTS TO ENHANCE PATIENT ENGAGEMENT AND PROVIDE REAL-TIME HEALTH SUPPORT
• 7.4 REMOTE PATIENT MONITORING
  • 7.4.1 EFFECTIVE REAL-TIME DISEASE MONITORING WITHOUT IN-PATIENT VISITS TO DRIVE MARKET
• 7.5 VIRTUAL NURSING CARE PLATFORMS
  • 7.5.1 VIRTUAL NURSING PLATFORMS TO ELIMINATE NURSING SHORTAGES, REDUCE BURNOUT, AND PROVIDE HIGH-QUALITY CARE
• 7.6 CLINICAL DOCUMENTATION
  • 7.6.1 NEED FOR ACCURATE AND COMPLIANT MEDICAL RECORDS FOR VIRTUAL CONSULTATIONS TO AUGMENT MARKET GROWTH
• 7.7 ADMINISTRATIVE WORKFLOW
  • 7.7.1 EFFECTIVE RESOURCE MANAGEMENT AND OPERATIONAL EFFICIENCY TO AID MARKET GROWTH
• 7.8 ANALYTICS & REPORTING
  • 7.8.1 ADVANCED ANALYTICS & REPORTING TOOLS TO FOSTER BETTER CARE COORDINATION AND PROVIDE PERSONALIZED TREATMENTS
• 7.9 PATIENT ENGAGEMENT
  • 7.9.1 BETTER PATIENT ENGAGEMENT TO ADVANCE HEALTHCARE DELIVERY AND PROMOTE BETTER ADHERENCE TO TREATMENT PLANS
• 7.10 OTHER FUNCTIONS

8 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 PRIMARY CARE APPLICATIONS
  • 8.2.1 TECHNOLOGICAL ADVANCEMENTS AND DEMAND FOR PERSONALIZED HEALTHCARE DELIVERY TO PROPEL MARKET GROWTH
• 8.3 SPECIALTY CARE APPLICATIONS
  • 8.3.1 TELERADIOLOGY
    • 8.3.1.1 Reduced turnaround time for imaging reports and better access to radiologists in remote areas to support market growth
  • 8.3.2 TELECARDIOLOGY
    • 8.3.2.1 Real-time ECG interpretations and remote cardiac care for chronic patients to augment market growth
  • 8.3.3 TELENEUROLOGY
    • 8.3.3.1 Growing focus on advanced neurological care without in-person visits to aid market growth
  • 8.3.4 DIABETES
    • 8.3.4.1 Rising prevalence of diabetes to drive market
  • 8.3.5 RESPIRATORY DISORDERS
    • 8.3.5.1 Increasing incidence of respiratory diseases among geriatric population to propel market growth
  • 8.3.6 HYPERTENSION
    • 8.3.6.1 Need for constant monitoring and high prevalence of hypertension to boost market growth
  • 8.3.7 TELEDERMATOLOGY
    • 8.3.7.1 Increased occurrence of skin cancer to fuel market growth
  • 8.3.8 TELEPSYCHIATRY
    • 8.3.8.1 Shortage of mental health practitioners in rural areas to fuel uptake
  • 8.3.9 OTHER SPECIALTY CARE APPLICATIONS
• 8.4 TELEICU
  • 8.4.1 INCREASE IN EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF ER SPECIALISTS TO PROPEL MARKET GROWTH
• 8.5 OTHER APPLICATIONS

9 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HEALTHCARE PROVIDERS
  • 9.2.1 HOSPITALS
    • 9.2.1.1 Growing incidence of chronic diseases and increasing demand for high-quality care to aid market growth
  • 9.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
    • 9.2.2.1 Cost-effectiveness and reduced patient downtime to augment market growth
  • 9.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES
    • 9.2.3.1 Need for prolonged treatment for chronic diseases to support market growth
  • 9.2.4 HOME HEALTHCARE
    • 9.2.4.1 Demand for cost-effective solutions and low hospital readmissions to propel segment growth
  • 9.2.5 OTHER HEALTHCARE PROVIDERS
• 9.3 HEALTHCARE PAYERS
  • 9.3.1 HEALTHCARE PAYERS TO REDUCE OVERHEAD COSTS, MINIMIZE PAPER TRAILS, AND IMPROVE MEMBER SERVICES
• 9.4 PATIENTS
  • 9.4.1 EMERGENCE OF ADVANCED WEARABLE DEVICES AND USE OF AI IN PERSONALIZED PATIENT CARE TO FUEL MARKET GROWTH
• 9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.5.1 NEED FOR STREAMLINED DRUG DEVELOPMENT PROCESSES AND ENHANCED CLINICAL TRIAL PARTICIPATION TO DRIVE MARKET
• 9.6 MEDTECH COMPANIES
  • 9.6.1 MEDTECH COMPANIES TO IMPROVE DIAGNOSTIC ACCURACY AND FACILITATE PERSONALIZED TREATMENT PLANS
• 9.7 OTHER END USERS

10 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Government initiatives on digital health integration to drive adoption of telehealth and mHealth applications
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Favorable government initiatives to support market growth
  • 10.3.3 UK
    • 10.3.3.1 Growing reliance on digital healthcare platforms and increasing investments in remote mental health services to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 Favorable reimbursement for telemedicine solutions to spur market growth
  • 10.3.5 ITALY
    • 10.3.5.1 Strategic government regulations and high investments in healthcare digitalization to augment market growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Rapid expansion of eHealth sector and increased adoption of wearable technologies to favor market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Increasing private sector investments in digital infrastructure to boost market growth
  • 10.4.3 JAPAN
    • 10.4.3.1 High geriatric population and strong technological infrastructure to propel market growth
  • 10.4.4 INDIA
    • 10.4.4.1 Increased government focus on digital transformation in rural areas to aid market growth
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Increasing adoption of digital health solutions in public and private systems to aid market growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Favorable regulatory scenario to fuel market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Shortage of skilled healthcare workforce to support market growth
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Function footprint
    • 11.5.5.4 Application footprint
    • 11.5.5.5 Component footprint
    • 11.5.5.6 End-user footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.6.5.1 Detailed list of key startups/SMEs
    • 11.6.5.2 Competitive benchmarking of key startups/SMEs, by region
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7.1 FINANCIAL METRICS
  • 11.7.2 COMPANY VALUATION
• 11.8 BRAND/SOFTWARE COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES & APPROVALS
  • 11.9.2 DEALS

12 COMPANY PROFILE

• 12.1 KEY PLAYERS
  • 12.1.1 MEDTRONIC
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products/Services/Solutions offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches and approvals
      • 12.1.1.3.2 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 TELADOC HEALTH, INC.
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products/Services/Solutions offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches and upgrades
      • 12.1.2.3.2 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Right to win
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 KONINKLIJKE PHILIPS N.V.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products/Services/Solutions offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product approvals
      • 12.1.3.3.2 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Right to win
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 CISCO SYSTEMS, INC.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products/Services/Solutions offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches
      • 12.1.4.3.2 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Right to win
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 GE HEALTHCARE
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products/Services/Solutions offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches and approvals
      • 12.1.5.3.2 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Right to win
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 EPIC SYSTEMS CORPORATION
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products/Services/Solutions offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches and upgrades
      • 12.1.6.3.2 Deals
  • 12.1.7 ORACLE
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products/Services/Solutions offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches
      • 12.1.7.3.2 Deals
  • 12.1.8 DOXIMITY, INC.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products/Services/Solutions offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product upgrades
      • 12.1.8.3.2 Deals
      • 12.1.8.3.3 Other developments
  • 12.1.9 INCLUDED HEALTH, INC.
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products/Services/Solutions offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Deals
      • 12.1.9.3.2 Other developments
  • 12.1.10 ZOOM COMMUNICATIONS, INC.
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products/Services/Solutions offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Deals
  • 12.1.11 AMERICAN WELL
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products/Services/Solutions offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Product launches
      • 12.1.11.3.2 Deals
      • 12.1.11.3.3 Other developments
  • 12.1.12 SIEMENS HEALTHINEERS AG
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products/Services/Solutions offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Product approvals
  • 12.1.13 AMC HEALTH
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products/Services/Solutions offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Deals
  • 12.1.14 TELESPECIALISTS
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products/Services/Solutions offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Product launches
      • 12.1.14.3.2 Deals
      • 12.1.14.3.3 Other developments
  • 12.1.15 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.)
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products/Services/Solutions offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product launches
      • 12.1.15.3.2 Expansions
  • 12.1.16 CAREGILITY
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products/Services/Solutions offered
    • 12.1.16.3 Recent developments
      • 12.1.16.3.1 Product launches and upgrades
      • 12.1.16.3.2 Deals
      • 12.1.16.3.3 Other developments
  • 12.1.17 CVS HEALTH
    • 12.1.17.1 Business overview
    • 12.1.17.2 Products/Services/Solutions offered
    • 12.1.17.3 Recent developments
      • 12.1.17.3.1 Product launches and upgrades
  • 12.1.18 ALIVECOR, INC.
    • 12.1.18.1 Business overview
    • 12.1.18.2 Products/Services/Solutions offered
    • 12.1.18.3 Recent developments
      • 12.1.18.3.1 Product launches and approvals
      • 12.1.18.3.2 Deals
      • 12.1.18.3.3 Other developments
  • 12.1.19 ELATION
    • 12.1.19.1 Business overview
    • 12.1.19.2 Products/Services/Solutions offered
    • 12.1.19.3 Recent developments
      • 12.1.19.3.1 Deals
  • 12.1.20 HEALTHTAP, INC.
    • 12.1.20.1 Business overview
    • 12.1.20.2 Products/Services/Solutions offered
    • 12.1.20.3 Recent developments
      • 12.1.20.3.1 Product launches
      • 12.1.20.3.2 Deals
• 12.2 OTHER PLAYERS
  • 12.2.1 CURAI HEALTH
  • 12.2.2 ANDOR HEALTH
  • 12.2.3 K HEALTH
  • 12.2.4 TRANSCARENT
  • 12.2.5 BIOINTELLISENSE, INC.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

List of Tables

• TABLE 1 AI IN TELEHEALTH & TELEMEDICINE MARKET: INCLUSIONS & EXCLUSIONS
• TABLE 2 AI IN TELEHEALTH & TELEMEDICINE MARKET: STUDY ASSUMPTIONS
• TABLE 3 AI IN TELEHEALTH & TELEMEDICINE MARKET: RISK ANALYSIS
• TABLE 4 MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• TABLE 5 RECENT DEVELOPMENTS FOR REMOTE PATIENT MONITORING SYSTEMS
• TABLE 6 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011-2024
• TABLE 7 AI IN TELEHEALTH & TELEMEDICINE MARKET: ROLE IN ECOSYSTEM
• TABLE 8 AVERAGE TARIFF FOR HS CODE 9018 IN 2023
• TABLE 9 AVERAGE TARIFF FOR HS CODE 9021 IN 2023
• TABLE 10 AVERAGE TARIFF FOR HS CODE 9022 IN 2023
• TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 14 AI IN TELEHEALTH & TELEMEDICINE MARKET: REGULATORY STANDARDS
• TABLE 15 REGULATORY REQUIREMENTS IN NORTH AMERICA
• TABLE 16 REGULATORY REQUIREMENTS IN EUROPE
• TABLE 17 REGULATORY REQUIREMENTS IN ASIA PACIFIC
• TABLE 18 REGULATORY REQUIREMENTS IN LATIN AMERICA
• TABLE 19 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA
• TABLE 20 TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 21 TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 22 TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 23 TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 24 TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 25 TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 26 COST RANGE INVOLVED IN AI-BASED TELEHEALTH & TELEMEDICINE DEVICES (USD)
• TABLE 27 INDICATIVE PRICE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY COMPONENT, 2023
• TABLE 28 AVERAGE SELLING PRICE OF TELADOC CONSULTATIONS
• TABLE 29 AVERAGE PRICING TREND OF AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2022-2024 (USD)
• TABLE 30 AI IN TELEHEALTH & TELEMEDICINE MARKET: PORTER'S FIVE FORCES
• TABLE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS
• TABLE 32 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS
• TABLE 33 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
• TABLE 34 AI IN TELEHEALTH & TELEMEDICINE MARKET: UNMET NEEDS
• TABLE 35 AI IN TELEHEALTH & TELEMEDICINE MARKET: END-USER EXPECTATIONS
• TABLE 36 AI IN TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
• TABLE 37 CASE STUDY 1: TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH CAREGILITY VIRTUAL NURSING SOLUTION
• TABLE 38 CASE STUDY 2: TELADOC HEALTH TO PROVIDE MEDICARE ADVANTAGE PLAN FOR CLOSING GAPS AND BOOSTING QUALITY RATINGS
• TABLE 39 CASE STUDY 3: LMH HEALTH TO REDUCE NURSE WORKLOAD WITH VIRTUAL NURSING
• TABLE 40 AI IN TELEHEALTH & TELEMEDICINE MARKET: CPT CODES AND REIMBURSEMENT ANALYSIS
• TABLE 41 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 42 MAJOR COMPANIES OFFERING HARDWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
• TABLE 43 AI IN TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 44 AI IN TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION, 2022-2030 (THOUSAND UNITS)
• TABLE 45 MAJOR COMPANIES OFFERING SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
• TABLE 46 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 47 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 48 MAJOR COMPANIES OFFERING EHR-CENTRIC SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
• TABLE 49 EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 50 MAJOR COMPANIES OFFERING NON-EHR-CENTRIC SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
• TABLE 51 NON-EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 52 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 53 MAJOR COMPANIES OFFERING INTEGRATED SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
• TABLE 54 INTEGRATED SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 55 MAJOR COMPANIES OFFERING STANDALONE SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
• TABLE 56 STANDALONE SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 57 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 58 ON-PREMISES DEPLOYMENT MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 59 MAJOR COMPANIES OFFERING CLOUD-BASED DEPLOYMENT FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
• TABLE 60 CLOUD-BASED DEPLOYMENT MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 61 MAJOR COMPANIES OFFERING AI-BASED TELEHEALTH & TELEMEDICINE SERVICES
• TABLE 62 AI IN TELEHEALTH & TELEMEDICINE SERVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 63 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 64 MAJOR COMPANIES OFFERING VIRTUAL CARE CONSULTATIONS
• TABLE 65 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL CARE CONSULTATION, BY REGION, 2022-2030 (USD MILLION)
• TABLE 66 MAJOR COMPANIES OFFERING CHATBOTS & VIRTUAL ASSISTANTS
• TABLE 67 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR CHATBOTS & VIRTUAL ASSISTANTS, BY REGION, 2022-2030 (USD MILLION)
• TABLE 68 MAJOR COMPANIES OFFERING REMOTE PATIENT MONITORING
• TABLE 69 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING, BY REGION, 2022-2030 (USD MILLION)
• TABLE 70 MAJOR COMPANIES OFFERING VIRTUAL NURSING CARE
• TABLE 71 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL NURSING CARE PLATFORMS, BY REGION, 2022-2030 (USD MILLION)
• TABLE 72 MAJOR COMPANIES OFFERING CLINICAL DOCUMENTATION
• TABLE 73 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR CLINICAL DOCUMENTATION, BY REGION, 2022-2030 (USD MILLION)
• TABLE 74 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR ADMINISTRATIVE WORKFLOW, BY REGION, 2022-2030 (USD MILLION)
• TABLE 75 MAJOR COMPANIES OFFERING ANALYTICS & REPORTING
• TABLE 76 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR ANALYTICS & REPORTING, BY REGION, 2022-2030 (USD MILLION)
• TABLE 77 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT ENGAGEMENT, BY REGION, 2022-2030 (USD MILLION)
• TABLE 78 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
• TABLE 79 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 80 MAJOR COMPANIES OFFERING PRIMARY CARE APPLICATIONS
• TABLE 81 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PRIMARY CARE APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
• TABLE 82 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 83 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
• TABLE 84 TELERADIOLOGY MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 85 TELECARDIOLOGY MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 86 TELENEUROLOGY MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 87 MAJOR COMPANIES OFFERING SOLUTIONS FOR DIABETES
• TABLE 88 DIABETES MARKET, BY REGION 2022-2030 (USD MILLION)
• TABLE 89 MAJOR COMPANIES OFFERING SOLUTIONS FOR RESPIRATORY DISORDERS
• TABLE 90 RESPIRATORY DISORDERS MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 91 HYPERTENSION MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 92 TELEDERMATOLOGY MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 93 TELEPSYCHIATRY MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 94 OTHER SPECIALTY CARE APPLICATIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 95 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION, 2022-2030 (USD MILLION)
• TABLE 96 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
• TABLE 97 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 98 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 99 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
• TABLE 100 HOSPITALS MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 101 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 102 LONG-TERM CARE & ASSISTED LIVING FACILITIES MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 103 HOME HEALTHCARE MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 104 OTHER HEALTHCARE PROVIDERS MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 105 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022-2030 (USD MILLION)
• TABLE 106 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 2022-2030 (USD MILLION)
• TABLE 107 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2030 (USD MILLION)
• TABLE 108 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR MEDTECH COMPANIES, BY REGION, 2022-2030 (USD MILLION)
• TABLE 109 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2022-2030 (USD MILLION)
• TABLE 110 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 111 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
• TABLE 112 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 113 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 114 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 115 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 116 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 117 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 118 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 119 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 120 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 121 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 122 US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 123 US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 124 US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 125 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 126 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 127 US: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 128 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 129 US: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 130 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 131 CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 132 CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 133 CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 134 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 135 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 136 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 137 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 138 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 139 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
• TABLE 140 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 141 EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 142 EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 143 EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 144 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 145 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 146 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 147 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 148 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 149 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 150 GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 151 GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 152 GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 153 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 154 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 155 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 156 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 157 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 158 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 159 UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 160 UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 161 UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 162 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 163 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 164 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 165 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 166 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 167 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 168 FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 169 FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 170 FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 171 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 172 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 173 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 174 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 175 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 176 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 177 ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 178 ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 179 ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 180 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 181 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 182 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 183 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 184 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 185 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 186 SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 187 SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 188 SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 189 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 190 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 191 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 192 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 193 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 194 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 195 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 196 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 197 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 198 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 199 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 200 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 201 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 202 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 203 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
• TABLE 204 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 205 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 206 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 207 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 208 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 209 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 210 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 211 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 212 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 213 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 214 CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 215 CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 216 CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 217 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 218 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 219 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 220 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 221 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 222 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 223 JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 224 JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 225 JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 226 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 227 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 228 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 229 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 230 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 231 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 232 INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 233 INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 234 INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 235 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 236 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 237 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 238 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 239 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 240 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 241 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 242 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 243 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 244 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 245 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 246 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 247 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 248 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 249 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
• TABLE 250 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 251 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 252 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 253 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 254 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 255 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 256 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 257 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 258 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 259 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 260 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 261 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 262 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 263 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 264 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 265 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 266 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 267 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 268 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 269 MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 270 MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 271 MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 272 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 273 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 274 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 275 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 276 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDER BY END USER, 2022-2030 (USD MILLION)
• TABLE 277 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 278 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 279 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 280 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 281 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 282 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 283 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 284 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 285 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 286 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022-2030 (USD MILLION)
• TABLE 287 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 288 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 289 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 290 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 291 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 292 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 293 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 294 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 295 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 296 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 297 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 298 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 299 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 300 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 301 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 302 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 303 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 304 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 305 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
• TABLE 306 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
• TABLE 307 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
• TABLE 308 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
• TABLE 309 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
• TABLE 310 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
• TABLE 311 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 312 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
• TABLE 313 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
• TABLE 314 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET, JANUARY 2021-MARCH 2025
• TABLE 315 AI IN TELEHEALTH & TELEMEDICINE MARKET: DEGREE OF COMPETITION
• TABLE 316 AI IN TELEHEALTH & TELEMEDICINE MARKET: REGION FOOTPRINT
• TABLE 317 AI IN TELEHEALTH & TELEMEDICINE MARKET: FUNCTION FOOTPRINT
• TABLE 318 AI IN TELEHEALTH & TELEMEDICINE MARKET: APPLICATION FOOTPRINT
• TABLE 319 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPONENT FOOTPRINT
• TABLE 320 AI IN TELEHEALTH & TELEMEDICINE MARKET: END-USER FOOTPRINT
• TABLE 321 AI IN TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
• TABLE 322 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY REGION
• TABLE 323 AI IN TELEHEALTH & TELEMEDICINE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MARCH 2025
• TABLE 324 AI IN TELEHEALTH & TELEMEDICINE MARKET: DEALS, JANUARY 2022-MARCH 2025
• TABLE 325 MEDTRONIC: COMPANY OVERVIEW
• TABLE 326 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 327 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MARCH 2025
• TABLE 328 MEDTRONIC: DEALS, JANUARY 2022-MARCH 2025
• TABLE 329 TELADOC HEALTH, INC.: COMPANY OVERVIEW
• TABLE 330 TELADOC HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 331 TELADOC HEALTH, INC.: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-MARCH 2025
• TABLE 332 TELADOC HEALTH, INC.: DEALS, JANUARY 2022-MARCH 2025
• TABLE 333 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
• TABLE 334 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 335 KONINKLIJKE PHILIPS N.V.: PRODUCT APPROVALS, JANUARY 2022-MARCH 2025
• TABLE 336 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022-MARCH 2025
• TABLE 337 CISCO SYSTEMS, INC.: COMPANY OVERVIEW
• TABLE 338 CISCO SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 339 CISCO SYSTEMS, INC.: PRODUCT LAUNCHES, JANUARY 2022-MARCH 2025
• TABLE 340 CISCO SYSTEMS, INC.: DEALS, JANUARY 2022-MARCH 2025
• TABLE 341 GE HEALTHCARE: COMPANY OVERVIEW
• TABLE 342 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 343 GE HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MARCH 2025
• TABLE 344 GE HEALTHCARE: DEALS, JANUARY 2022-MARCH 2025
• TABLE 345 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
• TABLE 346 EPIC SYSTEMS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 347 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-MARCH 2025
• TABLE 348 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2022-MARCH 2025
• TABLE 349 ORACLE: COMPANY OVERVIEW
• TABLE 350 ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 351 ORACLE: PRODUCT LAUNCHES, JANUARY 2022-MARCH 2025
• TABLE 352 ORACLE: DEALS, JANUARY 2022-MARCH 2025
• TABLE 353 DOXIMITY, INC.: COMPANY OVERVIEW
• TABLE 354 DOXIMITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 355 DOXIMITY, INC.: PRODUCT UPGRADES, JANUARY 2022-MARCH 2025
• TABLE 356 DOXIMITY, INC.: DEALS, JANUARY 2022-MARCH 2025
• TABLE 357 DOXIMITY, INC.: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
• TABLE 358 INCLUDED HEALTH, INC.: COMPANY OVERVIEW
• TABLE 359 INCLUDED HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 360 INCLUDED HEALTH, INC.: DEALS, JANUARY 2022-MARCH 2025
• TABLE 361 INCLUDED HEALTH, INC.: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
• TABLE 362 ZOOM COMMUNICATIONS, INC.: COMPANY OVERVIEW
• TABLE 363 ZOOM COMMUNICATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 364 ZOOM COMMUNICATIONS, INC.: DEALS, JANUARY 2022-MARCH 2025
• TABLE 365 AMERICAN WELL: COMPANY OVERVIEW
• TABLE 366 AMERICAN WELL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 367 AMERICAN WELL: PRODUCT LAUNCHES, JANUARY 2022-MARCH 2025
• TABLE 368 AMERICAN WELL: DEALS, JANUARY 2022-MARCH 2025
• TABLE 369 AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
• TABLE 370 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
• TABLE 371 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 372 SIEMENS HEALTHINEERS AG: PRODUCT APPROVALS, JANUARY 2022-MARCH 2025
• TABLE 373 AMC HEALTH: COMPANY OVERVIEW
• TABLE 374 AMC HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 375 AMC HEALTH: DEALS, JANUARY 2022-MARCH 2025
• TABLE 376 TELESPECIALISTS: COMPANY OVERVIEW
• TABLE 377 TELESPECIALISTS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 378 TELESPECIALISTS: PRODUCT LAUNCHES, JANUARY 2022-MARCH 2025
• TABLE 379 TELESPECIALISTS: DEALS, JANUARY 2022-MARCH 2025
• TABLE 380 TELESPECIALISTS: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
• TABLE 381 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY OVERVIEW
• TABLE 382 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 383 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCT LAUNCHES, JANUARY 2022-MARCH 2025
• TABLE 384 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): EXPANSIONS, JANUARY 2022-MARCH 2025
• TABLE 385 CAREGILITY: COMPANY OVERVIEW
• TABLE 386 CAREGILITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 387 CAREGILITY: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-MARCH 2025
• TABLE 388 CAREGILITY: DEALS, JANUARY 2022-MARCH 2025
• TABLE 389 CAREGILITY: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
• TABLE 390 CVS HEALTH: COMPANY OVERVIEW
• TABLE 391 CVS HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 392 CVS HEALTH: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-MARCH 2025
• TABLE 393 ALIVECOR, INC.: COMPANY OVERVIEW
• TABLE 394 ALIVECOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 395 ALIVECOR, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-MARCH 2025
• TABLE 396 ALIVECOR, INC.: DEALS, JANUARY 2022-MARCH 2025
• TABLE 397 ALIVECOR, INC.: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
• TABLE 398 ELATION: COMPANY OVERVIEW
• TABLE 399 ELATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 400 ELATION: DEALS, JANUARY 2022-MARCH 2025
• TABLE 401 HEALTHTAP, INC.: COMPANY OVERVIEW
• TABLE 402 HEALTHTAP, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 403 HEALTHTAP, INC.: PRODUCT LAUNCHES, JANUARY 2022-MARCH 2025
• TABLE 404 HEALTHTAP, INC.: DEALS, JANUARY 2022-MARCH 2025
• TABLE 405 CURAI HEALTH: COMPANY OVERVIEW
• TABLE 406 ANDOR HEALTH: COMPANY OVERVIEW
• TABLE 407 K HEALTH: COMPANY OVERVIEW
• TABLE 408 TRANSACARENT: COMPANY OVERVIEW
• TABLE 409 BIOINTELLISENSE, INC.: COMPANY OVERVIEW

List of Figures

• FIGURE 1 AI IN TELEHEALTH & TELEMEDICINE MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE
• FIGURE 2 AI IN TELEHEALTH & TELEMEDICINE MARKET: YEARS CONSIDERED
• FIGURE 3 AI IN TELEHEALTH & TELEMEDICINE MARKET: RESEARCH DESIGN
• FIGURE 4 AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM SECONDARY SOURCES
• FIGURE 5 AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY PRIMARY SOURCES
• FIGURE 6 AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM PRIMARY SOURCES
• FIGURE 7 AI IN TELEHEALTH & TELEMEDICINE MARKET: INSIGHTS FROM PRIMARIES
• FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 9 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
• FIGURE 10 AI IN TELEHEALTH & TELEMEDICINE MARKET: TOP-DOWN APPROACH
• FIGURE 11 AI IN TELEHEALTH & TELEMEDICINE MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2030)
• FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• FIGURE 13 AI IN TELEHEALTH & TELEMEDICINE MARKET: DATA TRIANGULATION
• FIGURE 14 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
• FIGURE 15 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION)
• FIGURE 16 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
• FIGURE 17 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
• FIGURE 18 AI IN TELEHEALTH & TELEMEDICINE MARKET: REGIONAL SNAPSHOT
• FIGURE 19 TECHNOLOGICAL ADVANCEMENTS AND NEED TO REDUCE HEALTHCARE EXPENSES TO PROPEL MARKET GROWTH
• FIGURE 20 US AND SOFTWARE SEGMENT DOMINATED NORTH AMERICAN MARKET IN 2023
• FIGURE 21 CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030
• FIGURE 22 EMERGING MARKETS TO GROW AT HIGHER RATES DURING STUDY PERIOD
• FIGURE 23 AI IN TELEHEALTH & TELEMEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 24 AMERICAN HOSPITAL ASSOCIATION (AHA) ANNUAL SURVEY ON EHR ADOPTION AMONG HOSPITALS AND OFFICE-BASED PHYSICIANS (2008-2021)
• FIGURE 25 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009-2024
• FIGURE 26 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009-2023
• FIGURE 27 AI IN TELEHEALTH & TELEMEDICINE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• FIGURE 28 AI IN TELEHEALTH & TELEMEDICINE MARKET: ECOSYSTEM ANALYSIS
• FIGURE 29 AI IN TELEHEALTH & TELEMEDICINE MARKET: VALUE CHAIN ANALYSIS
• FIGURE 30 AI IN TELEHEALTH & TELEMEDICINE MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS
• FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS
• FIGURE 33 GLOBAL PATENT PUBLICATION TRENDS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, 2015-2025
• FIGURE 34 JURISDICTION & TOP APPLICANT ANALYSIS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES
• FIGURE 35 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES (JANUARY 2015-MARCH 2025)
• FIGURE 36 AI IN TELEHEALTH & TELEMEDICINE MARKET: FUNDING AND NUMBER OF DEALS, 2021-2024
• FIGURE 37 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT
• FIGURE 38 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT
• FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET, 2020-2024 (USD MILLION)
• FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET (2023)
• FIGURE 41 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• FIGURE 42 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY FOOTPRINT
• FIGURE 43 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
• FIGURE 44 EV/EBITDA OF KEY AI-BASED TELEHEALTH & TELEMEDICINE PLAYERS, 2024
• FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF AI-BASED TELEHEALTH & TELEMEDICINE PLAYERS, 2024
• FIGURE 46 AI IN TELEHEALTH & TELEMEDICINE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
• FIGURE 47 MEDTRONIC: COMPANY SNAPSHOT
• FIGURE 48 TELADOC HEALTH, INC.: COMPANY SNAPSHOT
• FIGURE 49 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
• FIGURE 50 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT
• FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT
• FIGURE 52 ORACLE: COMPANY SNAPSHOT
• FIGURE 53 DOXIMITY, INC.: COMPANY SNAPSHOT
• FIGURE 54 ZOOM COMMUNICATIONS, INC.: COMPANY SNAPSHOT
• FIGURE 55 AMERICAN WELL: COMPANY SNAPSHOT
• FIGURE 56 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
• FIGURE 57 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY SNAPSHOT
• FIGURE 58 CVS HEALTH: COMPANY SNAPSHOT